Genes, chromosomes and the treatment of bladder cancer

Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)

Surgical challenges to retroperitoneal sarcomas

Treatment approaches for desmoid tumours

Development and expansion of the IFOM-IEO campus

Standard of care for neo-adjuvant therapy in HER 2 and triple negative subtype

Clinical trials and drug developments in pancreatic cancer

The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast conservation surgery

Histology and non-histology driven therapy for soft tissue sarcomas and the Rare Cancers Europe initiative

MET inhibitors for non-small cell lung cancer

Multidisciplinary benefits to radiotherapy

Pathology and development of ovarian cancer